shortagewatch

Home / Cardiovascular system / Irbesartan and Diuretics

ATC C09DA04 · Agents Acting On The Renin-Angiotensin System

Irbesartan and Diuretics shortage

As of 31 Oct 2026, Irbesartan and Diuretics has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 11 products.

Countries3/5
Products11packs or presentations
Short since26 Sep 20224.1 years ago
Earliest return6 Nov 2026company estimate
No return date6products
Main reasonManufacturing problem

Timeline

ItalySpainBelgium
2023202420252026IRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAIRBESARTAN E IDROCLOROTIAZIDE MYLANIRBESARTAN E IDROCLOROTIAZIDE MYLANIRBESARTAN E IDROCLOROTIAZIDE MYLANIRBESARTAN E IDROCLOROTIAZIDE MYLANIRBESARTAN E IDROCLOROTIAZIDE MYLANIRBESARTAN E IDROCLOROTIAZIDE MYLANIRBESARTAN/HIDROCLOROTIAZIDA VIATRIS 300 MG/IRBESARTAN/HIDROCLOROTIAZIDA VIATRIS 300 MG/25 MG COMPRIMIDOS EFG, 28 comprimidosIRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 150IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidosIRBESARTAN/HIDROCLOROTIAZIDA VIATRIS 300 MG/IRBESARTAN/HIDROCLOROTIAZIDA VIATRIS 300 MG/12.5 MG COMPRIMIDOS EFG, 28 comprimidosIrbesartan/Hydrochloorthiazide Sandoz 300 mgIrbesartan/Hydrochloorthiazide Sandoz 300 mg - 12.5 mg film-coat. tabl. 98CoAprovel 300 mg - 12.5 mg film-coat. tabl. CoAprovel 300 mg - 12.5 mg film-coat. tabl. 98today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAZENTIVA K.S.26 Sep 2022not givenManufacturing problem
Problemi produttivi
ITIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAZENTIVA K.S.30 Sep 2023not givenManufacturing problem
Problemi produttivi
ITIRBESARTAN HYDROCLOROTHIAZIDE ZENTIVAZENTIVA K.S.31 Dec 2023not givenManufacturing problem
Problemi produttivi
ITIRBESARTAN E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.15 May 2026not givenManufacturing problem
Problemi produttivi
ITIRBESARTAN E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.1 Jun 2026not givenManufacturing problem
Problemi produttivi
ITIRBESARTAN E IDROCLOROTIAZIDE MYLANMYLAN S.P.A.1 Oct 2026not givenManufacturing problem
Problemi produttivi
ESIRBESARTAN/HIDROCLOROTIAZIDA VIATRIS 300 MG/25 MG COMPRIMIDOS EFG, 28 comprimidosViatris Limited29 Sep 20269 Dec 2026Not stated
ESIRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidosKern Pharma S.L.22 Oct 202629 Dec 2026Not stated
ESIRBESARTAN/HIDROCLOROTIAZIDA VIATRIS 300 MG/12.5 MG COMPRIMIDOS EFG, 28 comprimidosViatris Limited28 Oct 202621 Jan 2027Not stated
BEIrbesartan/Hydrochloorthiazide Sandoz 300 mg - 12.5 mg film-coat. tabl. 98Sandoz12 Aug 20266 Nov 2026Manufacturing problem
Delay in production
BECoAprovel 300 mg - 12.5 mg film-coat. tabl. 98Sanofi Winthrop Industrie5 Oct 202618 Dec 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply